We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RHI icon
576
Robert Half
RHI
$4.07B
$963K 0.01%
12,808
-72,139
-85% -$5.15M
TAP icon
577
Molson Coors Class B
TAP
$7.71B
$955K 0.01%
14,509
EXAS
578
DELISTED
Exact Sciences
EXAS
$931K 0.01%
9,919
-7,267
-42% -$567K
MPWR icon
579
Monolithic Power Systems
MPWR
$65.8B
$930K 0.01%
1,721
-5,120
-75% -$2.43M
GLUE icon
580
Monte Rosa Therapeutics
GLUE
$1.91B
$925K 0.01%
+135,000
New +$873K
FWONA icon
581
Liberty Media Series A
FWONA
$22.6B
$910K 0.01%
+14,056
New +$889K
MFC icon
582
Manulife Financial
MFC
$73.2B
$910K 0.01%
48,090
-106,105
-69% -$2.03M
AVTR icon
583
Avantor
AVTR
$8.03B
$909K 0.01%
44,233
-113,494
-72% -$2.29M
EXR icon
584
Extra Space Storage
EXR
$31.3B
$908K 0.01%
6,099
-7,544
-55% -$1.14M
WDC icon
585
Western Digital
WDC
$172B
$904K 0.01%
31,531
-25,400
-45% -$707K
ENB icon
586
Enbridge
ENB
$121B
$903K 0.01%
24,266
INFY icon
587
Infosys
INFY
$47.4B
$900K 0.01%
56,000
-12,000
-18% -$188K
TNDM icon
588
Tandem Diabetes Care
TNDM
$1.18B
$898K 0.01%
36,587
PAYC icon
589
Paycom
PAYC
$7.05B
$897K 0.01%
2,793
-2,380
-46% -$702K
TW icon
590
Tradeweb Markets
TW
$21.7B
$896K 0.01%
13,084
+6,827
+109% +$484K
NTAP icon
591
NetApp
NTAP
$33.3B
$891K 0.01%
11,663
-12,244
-51% -$827K
ACHC icon
592
Acadia Healthcare
ACHC
$2.99B
$878K 0.01%
11,019
-14,634
-57% -$1.06M
NTR icon
593
Nutrien
NTR
$32.4B
$869K 0.01%
14,701
TYL icon
594
Tyler Technologies
TYL
$13B
$869K 0.01%
2,086
-2,346
-53% -$903K
AOS icon
595
A.O. Smith
AOS
$8.61B
0
CNQ icon
596
Canadian Natural Resources
CNQ
$93.4B
$867K 0.01%
30,798
EQH icon
597
Equitable Holdings
EQH
$13.3B
$863K 0.01%
31,776
-124,971
-80% -$3.16M
KMX icon
598
CarMax
KMX
$8.29B
$853K 0.01%
10,188
-7,333
-42% -$537K
HEI.A icon
599
HEICO Corp Class A
HEI.A
$36.3B
$849K 0.01%
6,036
-1,384
-19% -$186K
EQT icon
600
EQT Corp
EQT
$32.5B
$840K 0.01%
20,429
-4,974
-20% -$176K

Similar funds

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.